Mike Hollan

The platforms are described as being first-in-category for the pharma industry.

Alkermes’ chief information officer discusses how he helped develop and build a welcoming workplace.

Multiple surveys show that older voters are concerned about the cost of healthcare and Medicare, along with other financial concerns.

The company will present research from multiple projects completed in collaboration with multiple partners.

The company will offer clients access to spectral data files.

The Statistical Computing Environment Coalition aims to improve data flow and gets drugs approved more quickly.

Slack, CEO and chairman for START Center for Cancer Research, discusses the complications that patients have getting enrolled in clinical trials.

The CEO of AION Labs discusses both the new ways that AI is being implemented in drug development and why Israel is becoming the center of AI development in the pharma industry.

The company is collaborating with CPESN USA to bring more services to customers at independent pharmacies across the country.

Cityblock is partnering with Sunshine Health in Florida.

Cencora’s associate director of value and access strategy for its commercialization strategy & access solutions division discusses the current state of pre-approval information exchanges.

Inizio’s chief operations officer discusses how pharmaceutical companies are tailoring their product launch strategies to meet the diverse needs of stakeholders.

Experts discuss how new innovations are changing the relationship the industry has with patients.

Experts discuss how attempts to solve the drug pricing problem in the US are working.

Experts discuss how the upcoming election is impacting the pharma industry, and how either party’s victory could change the landscape in the following years.

Tala Fakhouri spoke at the conference about FDA’s approach to determining when it even needs to regulate the usage of AI in the pharma industry.

Industry experts gather to discuss the current investor market and how the IRA may impact the industry in the coming years.

The platform will use AI technology to provide pharmacists with more tools.

Carta Healthcare’s co-founder discusses how a recent ruling on non-compete clauses may help alleviate the coming nursing shortage.

The NABIP expressed frustration at CMS’ statement for placing blame on brokers and agents and not acknowledging evidence that switches were made by automated programs.

The CEO of ActiGraph discusses how these devices are changing patient monitoring in clinical trials.

Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is.

A greater shift from paper records and physical assets is achievable.

From Big Pharma to biotech—and a globe-spanning journey along the way—Yvonne Greenstreet, this year’s Healthcare Businesswomen’s Association Woman of the Year, is right where she wants to be: leading efforts to advance “bold ideas” in RNAi therapeutics into life-changing gains for patients.

The National Institute for Public Employee Healthcare Policy attributed the importance to the rising cost of health care.

Respondents said they were concerned about their own mental health or the mental health of another person at higher rates since 2022.

Cencora’s vice president of product management, global products & solutions Beth Riggio discusses the issues the industry faces with recalls and how it can improve.

The new care center will offer primary care services to uninsured and underinsured patients in the Wilmington, North Carolina, area.

RxLink will incorporate Cost Plus’ prices into its drug pricing platform MedMap.

The founder and CEO of UpScriptHealth discusses the issues causing the shortage and how recent decisions from the DEA may help solve the issue.